Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S5W-19618 · Session 5

Further to the answers to questions S5W-18944 and S5W-19151 by Jeane Freeman on 27 September and 4 October 2018 respectively, how many peop…

Answered Asked by Brian Whittle Con Lodged 25 Oct 2018

The question

To ask the Scottish Government, further to the answers to questions S5W-18944 and S5W-19151 by Jeane Freeman on 27 September and 4 October 2018 respectively, how many people have accessed the cystic fibrosis drug, Orkambi, through the Peer Approved Clinical System (PACS) Tier Two Panel.

The answer

Answered by Jeane Freeman on 2 Nov 2018 · 8 days after it was lodged, on time

There were six requests for Orkambi through the Peer Approved Clinical System (PACS) Tier Two process between 1 June 2018 and 31 September 2018. Four of these were accepted and two decisions were deferred by the relevant Health Boards for further consideration.

In the Official Report

No contribution in the Official Report cites S5W-19618 by reference.